Sorafenib in Advanced Hepatocellular Carcinoma
In patients with advanced hepatocellular carcinoma, median survival and the time to radiologic progression were nearly 3 months longer for patients treated with sorafenib than f...
Publications
View AllAutoantibodies against type I IFNs in patients with life-threatening COVID-19
The genetics underlying severe COVID-19 The immune system is complex and involves many genes, including those that encode cytokines known as interferons (IFNs). Individuals that...
Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy
In this retrospective cohort study of critically ill patients admitted to ICUs in Lombardy, Italy, with laboratory-confirmed COVID-19, most patients required IMV. The mortality ...
Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?
If liver transplantation is not feasible, partial resection is considered the treatment of choice for hepatocellular carcinoma (HCC) in patients with cirrhosis. However, in some...
Unanswered Questions for Management of Acute Coronary Syndrome
Abstract The Data Quality Monitoring (DQM) of CMS is a key asset to deliver high-quality data for physics analysis and it is used both in the online and offline environment. The...
Evidence that Prefibrotic Myelofibrosis Is Aligned along a Clinical and Biological Continuum Featuring Primary Myelofibrosis
Pre-MF is a presentation mode of PMF with a very indolent phenotype. The major consequences of this contention is a new clinical vision of PMF, and the need to improve prognosis...
Affiliated Researchers
Institution Info
- Type
- healthcare
- Country
- IT
- Publications
- 9
- Citations
- 20,458
External Links
Identifiers
- ROR
- https://ror.org/05w1q1c88